Catalyst Wire Dossier Catalyst Wire Dossier

CD28 modulator for regulatory T cell modulation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD28 modulator for regulatory T cell modulation, covering 2024-10-09 to 2024-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Treg Modulation With CD28 and IL-6 Receptor Antagonists [Phase 1, Phase 2]

See pricing